Manji H
Manji H
Unknown affiliation
Verified email at its.jnj.com
Title
Cited by
Cited by
Year
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression
CA Zarate, JB Singh, PJ Carlson, NE Brutsche, R Ameli, DA Luckenbaugh, ...
Archives of general psychiatry 63 (8), 856-864, 2006
27952006
The cellular neurobiology of depression
HK Manji, WC Drevets, DS Charney
Nature medicine 7 (5), 541-547, 2001
13752001
Discovering endophenotypes for major depression
G Hasler, WC Drevets, HK Manji, DS Charney
Neuropsychopharmacology 29 (10), 1765-1781, 2004
11902004
New insights into BDNF function in depression and anxiety
K Martinowich, H Manji, B Lu
Nature neuroscience 10 (9), 1089-1093, 2007
10442007
Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders
G Sanacora, CA Zarate, JH Krystal, HK Manji
Nature reviews Drug discovery 7 (5), 426-437, 2008
8332008
A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression
N Diazgranados, L Ibrahim, NE Brutsche, A Newberg, P Kronstein, ...
Archives of general psychiatry 67 (8), 793-802, 2010
8122010
The American psychiatric publishing textbook of psychopharmacology
AF Schatzberg, CB Nemeroff
American Psychiatric Pub, 2009
6812009
Enhancement of hippocampal neurogenesis by lithium
G Chen, G Rajkowska, F Du, N Seraji‐Bozorgzad, HK Manji
Journal of neurochemistry 75 (4), 1729-1734, 2000
6722000
Preclinical models: status of basic research in depression
EJ Nestler, E Gould, H Manji
Biological psychiatry 52 (6), 503-528, 2002
6282002
Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression
HK Manji, JA Quiroz, J Sporn, JL Payne, K Denicoff, NA Gray, ...
Biological psychiatry 53 (8), 707-742, 2003
5862003
The mood‐stabilizing agent valproate inhibits the activity of glycogen synthase kinase‐3
G Chen, LD Huang, YM Jiang, HK Manji
Journal of neurochemistry 72 (3), 1327-1330, 2000
5612000
The Mood‐Stabilizing Agents Lithium and Valproate RobustlIncrease the Levels of the Neuroprotective Protein bcl‐2 in the CNS
G Chen, WZ Zeng, PX Yuan, LD Huang, YM Jiang, ZH Zhao, HK Manji
Journal of neurochemistry 72 (2), 879-882, 1999
5611999
The role of the extracellular signal-regulated kinase signaling pathway in mood modulation
H Einat, P Yuan, TD Gould, J Li, JH Du, L Zhang, HK Manji, G Chen
Journal of Neuroscience 23 (19), 7311-7316, 2003
5502003
Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment
FJ McMahon, S Buervenich, D Charney, R Lipsky, AJ Rush, AF Wilson, ...
The American Journal of Human Genetics 78 (5), 804-814, 2006
4992006
Toward constructing an endophenotype strategy for bipolar disorders
G Hasler, WC Drevets, TD Gould, II Gottesman, HK Manji
Biological psychiatry 60 (2), 93-105, 2006
4772006
Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2’s neurotrophic effects?
GJ Moore, JM Bebchuk, K Hasanat, G Chen, N Seraji-Bozorgzad, IB Wilds, ...
Biological psychiatry 48 (1), 1-8, 2000
4532000
Life stress, genes, and depression: multiple pathways lead to increased risk and new opportunities for intervention
DS Charney, HK Manji
Science's STKE 2004 (225), re5-re5, 2004
4462004
Mood stabilizer valproate promotes ERK pathway-dependent cortical neuronal growth and neurogenesis
Y Hao, T Creson, L Zhang, P Li, F Du, P Yuan, TD Gould, HK Manji, ...
Journal of Neuroscience 24 (29), 6590-6599, 2004
4332004
Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics.
HK Manji, RS Duman
Psychopharmacology bulletin 35 (2), 5, 2001
4212001
Signal transduction pathways: molecular targets for lithium's actions
HK Manji, WZ Potter, RH Lenox
Archives of General Psychiatry 52 (7), 531-543, 1995
4161995
The system can't perform the operation now. Try again later.
Articles 1–20